# OnCo record velavigo (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/velavigo/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "velavigo" ;
  schema:name "VelaVigo"@en ;
  schema:alternateName "VelaVigo Bio"@en, "橙帆医药"@en ;
  schema:description "VelaVigo is a China-based biotechnology company that leads 3 cancer trials in OnCo, testing the bispecific antibody-drug conjugates VBC101, VBC103 and VBC108 in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/velavigo/>, <https://www.velavigo.com> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.velavigo.com>, <https://clinicaltrials.gov/search?lead=VelaVigo%20Bio%20Inc> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:trials <https://onco.cc/trials/nct07299747/>, <https://onco.cc/trials/nct07136779/>, <https://onco.cc/trials/nct07700160/> .
